Oxford Gene Technology (OGT), A Sysmex Group Company, will be hosting a live workshop at the upcoming Association for Molecular Pathology (AMP) 2020 virtual meeting, in which users will explain how OGT’s SureSeq™ NGS panels can increase throughput and save time and cost in the detection of a wide variety of aberrations. The workshop, Implementing SureSeq Myeloid and CLL Panels for comprehensive genomic profiling of haematological malignancies, will be held on Wednesday 18th November at 4:30 PM EST. To find out more and to register for the workshop, visit www.ogt.com/AMP-2020. During the workshop, Tracy Tucker, PhD, FCCMG, Cytogeneticist and Molecular Geneticist, Cancer Genetics and Genomics, BC Cancer Agency, and Associate Professor, University of British Columbia, will be talking about transitioning CLL FISH analysis into the molecular biomarker era using OGT’s SureSeq CLL + CNV panel. Her presentation will be followed by Elizabeth McCready, PhD, FCCMG, Head of Molecular Cytogenetics, Hamilton Regional Laboratory Medicine Program, and Associate Professor, McMaster University, who will compare a hybridization-based NGS panel versus single analyte and amplicon-based NGS assays for somatic mutation testing in myeloid malignancies, from her experience with OGT’s SureSeq myPanel Custom Myeloid – 49 gene plus panel.